Woo Jae-Hyug, Lim Yong Su, Yang Hyuk Jun, Hyun Sung Youl, Cho Jin Seong, Kim Jin Joo, Lee Gun
Department of Emergency and Critical Care Medicine, Gachon University Gil Medical Center, 1198, Guwol-dong, Namdong-gu, Incheon, 405-760, South Korea.
Neurocrit Care. 2017 Jun;26(3):402-410. doi: 10.1007/s12028-016-0353-8.
Hyperglycemia in out-of-hospital cardiac arrest (OHCA) survivors is associated with poor outcomes. However, in the control of initial hyperglycemia, an adequate strategy to improve patients' neurologic outcomes remains undetermined. Prior to the establishment of such strategy, we need to determine whether a decreased rate of initial blood glucose (BG) affects patient outcomes.
One hundred and forty-five adult non-traumatic OHCA survivors treated with therapeutic hypothermia between April 2007 and December 2011 were enrolled in this single-center retrospective cohort study. Based on the cerebral performance category (CPC) at 6 months after OHCA, study populations were categorized as "Good CPC group" (favorable outcome, CPC1 and CPC2) and "Poor CPC group" (unfavorable outcome, CPC3-CPC5). Variables related to BG were obtained, and the rate of BG change was calculated.
In the Good CPC group, the time required to attain target BG levels was shorter [7.4 (2.97-18.13) vs. 13.17 (7.55-27.0) h, p < 0.001], and the average rate of glucose decrease until the attainment of target BG levels was faster [17.06 (6.67-34.49) vs. 8.33 (4.26-18.55) mg/dl/h, p = 0.005] than in the Poor CPC group. Using multivariate analysis, the faster rate (odds ratio 1.074; 95% confidence interval 1.029-1.12; p = 0.001) and the shorter time (odds ratio 13.888; 95% confidence interval 2.271-84.906; p = 0.004) required to attain target BG levels were independently related to favorable neurologic outcomes.
Faster rates of initial BG decrease and the shorter time required to attain target BG levels were associated with favorable neurologic outcome in survivors of OHCA receiving therapeutic hypothermia.
院外心脏骤停(OHCA)幸存者的高血糖与不良预后相关。然而,在控制初始高血糖方面,改善患者神经学预后的适当策略仍未确定。在确立此类策略之前,我们需要确定初始血糖(BG)下降速率是否会影响患者预后。
2007年4月至2011年12月期间接受治疗性低温治疗的145例成年非创伤性OHCA幸存者被纳入这项单中心回顾性队列研究。根据OHCA后6个月的脑功能分类(CPC),将研究人群分为“良好CPC组”(预后良好,CPC1和CPC2)和“不良CPC组”(预后不良,CPC3 - CPC5)。获取与BG相关的变量,并计算BG变化率。
在良好CPC组中,达到目标BG水平所需的时间更短[7.4(2.97 - 18.13)小时对13.17(7.55 - 27.0)小时,p < 0.001],并且在达到目标BG水平之前血糖下降的平均速率更快[17.06(6.67 - 34.49)对8.33(4.26 - 18.55)mg/dl/小时,p = 0.005],优于不良CPC组。使用多变量分析,达到目标BG水平所需的更快速率(比值比1.074;95%置信区间1.029 - 1.12;p = 0.001)和更短时间(比值比13.888;95%置信区间2.271 - 84.906;p = 0.004)与良好的神经学预后独立相关。
在接受治疗性低温治疗的OHCA幸存者中,初始BG下降速率更快和达到目标BG水平所需时间更短与良好的神经学预后相关。